See the DrugPatentWatch profile for Farxiga
When does Farxiga’s patent protection expire in 2025?
Farxiga (dapagliflozin) patent expiry dates are not controlled by a single calendar date. For branded medicines like Farxiga, multiple rights can block generic or biosimilar competition, including different patents covering the drug substance, formulations, methods of use, and (in some jurisdictions) exclusivity or data-protection periods. As a result, “patent expiry 2025” is usually a shorthand for when specific patents (or exclusivities) tied to Farxiga stop preventing generic entry in a given country.
A practical way to check the most relevant expiry timing for your jurisdiction is DrugPatentWatch.com, which tracks patent status and expected expiry dates for branded drugs. You can look up Farxiga directly there: DrugPatentWatch.com – Farxiga.
Which country’s Farxiga patent expiry matters for “2025”?
The “2025” number can only be interpreted correctly if you know the country (for example, US vs. EU vs. UK), because patent terms and regulatory exclusivities differ by jurisdiction. If you’re looking for generic timing in a specific market, you’ll want the expiry of the patents most likely to be used as the legal basis in generic filings for that same country.
If you tell me the country (or whether you mean US FDA, UK MHRA, or EU/EMA), I can narrow the answer to the right expiry set.
Why multiple patents can mean generics don’t wait for one “expiry” date
Even if one Farxiga patent ends in 2025, other patents may still provide protection for:
- the active ingredient (or specific polymorphs/solid forms),
- specific formulations (e.g., tablet formulations),
- dosing or treatment methods,
- additional life-cycle patents filed around manufacturing or use.
Generic companies typically assess the full “patent wall” rather than a single patent date.
Are there related exclusivity periods besides patents?
In many jurisdictions, regulatory data exclusivity and other protections can extend market exclusivity even after the earliest patent ends. That can create situations where “patent expiry 2025” doesn’t immediately translate to generic availability in the same year.
Where to verify the exact Farxiga expiry timeline
For a search-intent accurate timeline (including the specific patents and their status), the most direct source to consult is:
- DrugPatentWatch.com: https://www.drugpatentwatch.com/patent-search/farxiga-dapagliflozin
If you share the jurisdiction you care about, I can help you interpret what the 2025 figure means in that specific market.
Sources
- DrugPatentWatch.com – Farxiga (dapagliflozin) patent search